Ointment Texture Analysis: Measuring Firmness, Adhesiveness & Spreadability

Ointment texture analysis is the instrumented measurement of consistency, firmness, adhesiveness and spreadability of pharmaceutical ointments using a texture analyzer equipped with a back extrusion cell, cone penetrometer and/or spreadability rig. For topical ointments — the hydrocarbon-based, anhydrous or water-in-oil emulsion semi-solids covered under USP <1724> Semi-Solid Drug Products — Performance Tests — texture analysis delivers an objective, electronic-record-compliant readout of product consistency that is far more sensitive and reproducible than the visual or gravimetric methods it replaced.

On the KHT TA-30, a single platform with interchangeable fixtures produces back extrusion force curves, cone penetration depth and 90°/45° spreadability energy within a 0.1–50 N force envelope at 0.01 N resolution, covering the full range of pharmaceutical ointments from soft hydroalcoholic bases to stiff petrolatum and zinc oxide formulations.

Ointment Texture Properties and Their Formulation Significance

Pharmaceutical ointments span a wide consistency range — from soft, easily spreadable hydrocarbon bases to stiff, gritty medicated pastes — and each consistency class demands a specific measurement geometry. Five texture properties dominate ointment characterisation: firmness (yield force), adhesiveness (withdrawal work), cohesiveness (TPA ratio), spreadability (Ortan energy) and apparent viscosity (back extrusion steady-state force).

Firmness controls how much force the patient must apply to extrude product from a tube. Too-firm ointments (>30 N peak extrusion force in a 45 mm back extrusion cell) produce poor patient compliance; too-soft ointments (<3 N) tend to leak from tubes during warm shipping. Adhesiveness governs how long the ointment stays in contact with skin — critical for wound-care and corticosteroid ointments where residence time determines therapeutic dose. Regulatory programmes — particularly US topical generic bioequivalence (Q3 microstructural sameness) and EU Annex 15 in-process control — now expect multi-parameter texture data as part of a complete ointment specification.

Choosing the Right Texture Analyzer Method for Ointment QC

Four methods cover virtually all pharmaceutical ointment texture analysis requirements. The choice depends on product consistency, available sample mass, and whether the specification prioritises patient-perceived application behaviour or process/filling behaviour.

• Back extrusion: the go-to method for stiff and medium-consistency ointments. A flat disc is driven into a cylindrical cell; product flows upward through the annular gap. More reproducible than a flat probe because the bounded flow geometry prevents product fracture and side spreading. Force curve shows a yield peak followed by a steady-state plateau; both are reportable parameters.
• Cone penetrometry (ASTM D217-equivalent): the classical ointment test cross-referenced in pharmacopoeial practice. A 45° standard cone is driven into the product at a controlled speed. Peak force at a defined depth, or penetration depth at a defined force, is reported. Well-suited to anhydrous petrolatum-based ointments where ASTM legacy data is available for benchmarking.
• Spreadability rig (45° Ortan): measures the work of spreading — patient-perceived ease of application. The 45° geometry is preferred over the 90° for ointments as it handles the higher force envelope (2–20 N typical) and is less prone to side leakage.
• Texture Profile Analysis (TPA): delivers the widest slate of parameters (hardness, cohesiveness, springiness, adhesiveness, gumminess) from a single test. Preferred for W/O emulsion ointments and medicated petrolatum bases where multiple parameters capture both structural and flow behaviour.
• Selection rule: for stiff anhydrous ointments (peak back extrusion force >15 N), start with back extrusion + cone penetrometry. For soft-to-medium ointments (3–15 N), start with TPA + spreadability rig.

Test Protocol: Back Extrusion, Cone Penetration & Spreadability

All methods require sample preparation: condition 25–50 g of product at 25.0 ± 0.5 °C for a minimum of 4 hours. For temperature-sensitive waxy ointments, extend conditioning to 12 hours or use the Peltier platform. The table below summarises consolidated method parameters for routine pharmaceutical ointment QC on the KHT TA-30.

Data Parameters: Firmness, Cohesiveness, Adhesive Force & Work

A routine pharmaceutical ointment QC report extracts the following parameters. Typical ranges are provided for a mid-consistency petrolatum-based ointment at 25 °C on the KHT TA-30. A pharmaceutical ointment release specification typically names three to five of these parameters with mean ± range acceptance criteria derived from the three process validation batches.

Setting Specification Limits and Interpreting Batch-to-Batch Variation

Specification setting for ointment texture parameters follows a three-stage process: process validation batches (PV1–3), capability assessment (Cp/Cpk), and specification window selection (typically mean ± 3σ constrained by clinical relevance).

In routine QC, out-of-specification results in ointment texture testing most commonly trace to four root causes: temperature drift (a 5 °C rise softens a typical petrolatum ointment by 15–25%); cooling-rate deviation during manufacture (faster cooling produces firmer ointments); mixing-shear deviation (over-shearing breaks down emulsion droplets and lowers firmness); and raw material specification drift (wax chain length, petrolatum grade and emulsifier HLB all strongly affect texture). Good QC practice is to log texture parameters on a statistical process control chart — trends are often detectable 3–5 batches before a batch goes OOS.

Step-by-Step Protocol

The following is the KHT TA-30 standard protocol for routine back-extrusion-based ointment QC. Protocols for cone penetrometry and TPA are available in the method library with analogous steps.

• Sample conditioning: Condition product at 25.0 ± 0.5 °C for a minimum of 4 hours (12 hours for waxy bases).
• Cell loading: Transfer product into the 50 mm cylindrical back extrusion cell to a depth of 30 mm using a scoop. Level the surface with a spatula. Avoid air entrainment.
• Instrument setup: Install the 5 kg load cell (10 kg for stiff pastes). Install the 45 mm back extrusion disc. Tare the load cell. Log in and recall the "Ointment Back Extrusion — USP <1724> Aligned" method.
• Positioning: Place the filled cell on the instrument platform, centred beneath the disc. Raise the platform until the disc is 10 mm above the product surface.
• Test execution: Press "Start". The disc descends at 2.0 mm/s until 0.1 N trigger, then at 1.0 mm/s through 25 mm travel, then withdraws at 10 mm/s. Data at 500 Hz is recorded to the audit trail.
• Parameter extraction: The software reports peak force, steady-state force (mean over 10–20 mm), area under curve, and — if the withdrawal curve was acquired — work of adhesion.
• Replicates: Remove and clean the cell and disc with IPA/water. Refill with fresh product (do not reuse the same aliquot). Repeat for a minimum of five replicates.
• Reporting: The software computes mean ± SD and %RSD and generates a signed PDF with raw curves, parameters, and the operator's electronic signature. The supervisor counter-signs before batch release.